Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05675956 · ClinicalTrials.gov registry record · NA
Acute Nerve Stimulation For Enhancing Human and Cognitive Performance
A NA study, sponsored by University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT05675956: Completed NA study, sponsored by University of South Carolina.
NCT05675956 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05675956, a NA study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test a wearable device's effect on performance in tactical populations with a history of concussion. The main question it aims to answer is the effectiveness of the device on modulate physiological and cognitive function. The physiological function will be derived from metrics of heart rate variability and blood-based biomarkers, whilst human performance will be evaluated using tasks that assess cognitive domains of executive function, reaction time, and memory.
Primary Outcome
To determine if the device has an impact on dopamine levels
Interventions
- DEVICE Experimental group with 100% intensity setting on Apollo Neuro device
- DEVICE Active Comparator group with 10% intensity setting on the Apollo Neuro device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2023-01-15 |
| Est. Completion | 2024-03-27 |
| Phase | NA |
What the finished NCT05675956 record still lists
NCT05675956 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental group with 100% intensity setting on Apollo Neuro device is the first listed.
NCT05675956 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05675956 about?
NCT05675956 is a clinical study titled "Acute Nerve Stimulation For Enhancing Human and Cognitive Performance". The goal of this clinical trial is to test a wearable device's effect on performance in tactical populations with a history of concussion. The main question it aims to answer is the effectiveness of the device on modulate physiological and cognitive function. The physiological function will be deri...
What is the current status of trial NCT05675956?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2023-01-15. Estimated completion is 2024-03-27.
What interventions are being tested in trial NCT05675956?
The interventions under investigation include: Experimental group with 100% intensity setting on Apollo Neuro device (DEVICE), Active Comparator group with 10% intensity setting on the Apollo Neuro device (DEVICE).
Who is sponsoring clinical trial NCT05675956?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05675956's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI